News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|October 25, 2017

Understanding Targeted Therapies

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Shared Loss Leads to Lifelong Friendship in Rare Cancer Caregiving

BySpencer Feldman

November 13th 2025

image of Fda.

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

November 13th 2025

Bonnie Annis

When One Blood Draw Could Tell More: A Look at the Cancerguard Test

November 13th 2025

FDA sign image

FDA Grants Drug Designation to Tinostamustine for Malignant Glioma

November 13th 2025

Image of FDA.

FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia

November 13th 2025

Trending on CURE

Cancer Experts Share Emerging Treatments Patients Should Know in 2026

FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO

Detalimogene Shows 62% Response Rate in Bladder Cancer Trial

© 2025 MJH Life Sciences^®

All rights reserved.